This document discusses WE Oncology, a cancer diagnostic and treatment center located in Dallas, TX. It offers medical and surgical treatments, radiation therapy, and focuses on blood cancers like leukemia and lymphoma. The center aims to improve its diagnostic rates of benign and malignant blood tumors. Its goals for the future are to become the leading diagnostic center in Texas within 5-7 years and one of the top requested centers for cancer care, treatment, and diagnosis in America. The document also evaluates two new medical imaging technologies: Revolution CT, which enables lower-dose 4D imaging but has risks of artifacts and difficulties with certain patients, and Multitom Rax, which performs multiple x-rays with a moving robot arm instead of moving the patient